Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Teresa, Andreani"'
Autor:
Eric B. Sirota, Aaron M. Whittaker, David J. Lamberto, Teresa Andreani, Thomas Kwok, Eric Margelefsky, Scott Quirie, Varsolona Richard J
Publikováno v:
Organic Process Research & Development. 25:308-317
Islatravir (MK-8591), a highly potent nucleoside reverse transcriptase translocation inhibitor, is being developed to stem the spread of global HIV infections. Following a nine-enzyme in vitro synt...
Autor:
Xiao Wang, Justin A. Newman, Aaron M. Whittaker, Heather C. Johnson, Teresa Andreani, Kevin M. Maloney, Niki R. Patel, Mark A. Huffman, Mark McLaughlin, Bangwei Ding
Publikováno v:
Chemistry – A European Journal. 26:14118-14123
A 5-step enantioselective synthesis of the potent anti-HIV nucleoside islatravir is reported. The highly efficient route was enabled by a novel enantioselective alkynylation of an α,β-unsaturated ketone, a unique ozonolysis-dealkylation cascade in
Autor:
Mark A. Huffman, Yingju Xu, Aaron M. Whittaker, Kevin M. Maloney, Teresa Andreani, David M. Tschaen, Andrew Brunskill, François Lévesque, Hongming Li, Christopher C. Nawrat, Mark McLaughlin, Hao Yang, Anna Fryszkowska, Niki R. Patel
Publikováno v:
Organic letters. 22(12)
The synthesis of the potent anti-HIV investigational treatment islatravir is described. The key step in this synthesis is a highly enantioselective catalytic asymmetric alkynylation of a ketone. This reaction is a rare example of the asymmetric addit
Autor:
Charles Lee Jayne, Santhosh Neelamkavil, Alan Hruza, Richard N. Ingram, Samuel Chackalamannil, Mariappan V. Chelliah, Keith Eagen, Teresa Andreani, William J. Greenlee, Kartik M. Keertikar, Steve Fried, Brian Hawes, Yan Xia, Zhuyan Guo, Michael P. Dwyer, Tin-Yau Chan, Paul Reichert, Martin C. Clasby
Publikováno v:
Bioorganicmedicinal chemistry letters. 30(15)
The synthesis and structure activity relationship development of a pyrimidine series of heterocyclic Factor IXa inhibitors is described. Increased selectivity over Factor Xa inhibition was achieved through SAR expansion of the P1 element. Select comp
Autor:
Mark Weisel, Hongming Li, Teresa Andreani, Christopher C. Nawrat, Aaron M. Whittaker, David M. Tschaen, Mark A. Huffman, Ryan D. Cohen, Mark McLaughlin, Bangwei Ding
Publikováno v:
Organic letters. 22(6)
A stereoselective nine-step synthesis of the potent HIV nucleoside reverse transcriptase translocation inhibitor (NRTTI) islatravir (EfdA, MK-8591) from 2-deoxyribose is described. Key findings include a diastereodivergent addition of an acetylide nu
Autor:
Teresa Andreani
Publikováno v:
Bioethica. 7:40
In the last three decades, the dilemma of End-of-Life is one of the most disputed bio-juridical questions Italy is confronting with. By raising highly sensitive ethical, legal and political dilemmas, it has deeply divided the Italian society, the sci
Autor:
Katrina W. Lexa, Daniel A. DiRocco, Zhijian Liu, Cheol K. Chung, Rebecca T. Ruck, Yining Ji, Teresa Andreani, Guy R. Humphrey, Yingju Xu
Publikováno v:
Journal of the American Chemical Society. 139:10637-10640
A weak Bronsted acid-catalyzed asymmetric guanidine aza-conjugate addition reaction has been developed. C2-symmetric, dual hydrogen-bond donating bistriflamides are shown to be highly effective in activating α,β-unsaturated esters toward the intram
Autor:
John S. Edwards, Teresa Andreani, Michael Williams, Hongmei Li, Jongrock Kong, Peter R. Mullens, Brian C. Bishop, Ed Cleator, Adrian Goodyear, Michael J. Zacuto, Yan Jin, Mark McLaughlin
Publikováno v:
Organic Process Research & Development. 20:1075-1087
Two new routes to a pyrimidyl tetrazole intermediate are described. The first-generation route featured an iron-catalyzed cross-coupling between 4-butenylmagnesium bromide and a 4-chloropyrimidine derivative to afford an alkene-bearing pyrimidine int
Autor:
Michael Shevlin, Melodie Christensen, Bangping Xiang, Michael R. Luzung, David M. Tschaen, Teresa Andreani, Stephen M. Dalby, Guy R. Humphrey, Zhiguo Jake Song, Kevin M. Belyk
Publikováno v:
Organic Process Research & Development. 20:1097-1103
The development of a concise asymmetric synthesis of the antiviral development candidate letermovir is reported, proceeding in >60% yield over a total of seven steps from commercially available materials. Key to the effectiveness of this process is a
Autor:
Aaron M. Whittaker, Teresa Andreani, Niki R. Patel, Mark A. Huffman, Bangwei Ding, Heather C. Johnson, Kevin M. Maloney, Justin A. Newman, Mark McLaughlin, Xiao Wang
Publikováno v:
Chemistry – A European Journal. 26:14023-14023